ArticleDrug design, development and therapy2024

Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation.

Guoquan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.